Corbus Pharmaceuticals Holdings (CRBP) Preferred Shares (2015 - 2017)
Corbus Pharmaceuticals Holdings (CRBP) posted Preferred Shares of $10.0 million for Q4 2017, little changed on a QoQ basis from $10.0 million in Q4 2016, and little changed year-over-year from $10.0 million in Q4 2016.
Analysis
Corbus Pharmaceuticals Holdings (CRBP) Preferred Shares (2015 - 2017) Analysis & Trends
Corbus Pharmaceuticals Holdings has reported Preferred Shares for 3 years, with the latest figure at $10.0 million in Q4 2017.
- On a quarterly basis, Preferred Shares changed 0.0% year-over-year to $10.0 million in Q4 2017; TTM through Dec 2017 was $10.0 million, a 0.0% change from a year earlier, with the FY2017 full-year figure at $10.0 million, changed 0.0% from the prior year.
- Preferred Shares was $10.0 million for Q4 2017 at Corbus Pharmaceuticals Holdings, roughly flat from $10.0 million in the prior quarter.
- The five-year high for Preferred Shares was $10.0 million in Q4 2015, with the low at $10.0 million in Q4 2015.
- Average Preferred Shares over 3 years is $10.0 million, with a median of $10.0 million recorded in 2015.
- The largest YoY upside for Preferred Shares was 0.0% in 2016 against a maximum downside of 0.0% in 2016.
- Over 3 years, Preferred Shares stood at $10.0 million in 2015, then changed by 0.0% to $10.0 million in 2016, then changed by 0.0% to $10.0 million in 2017.
- The last three Preferred Shares figures came in at $10.0 million (Q4 2017), $10.0 million (Q4 2016), and $10.0 million (Q4 2015), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Corbus Pharmaceuticals Holdings | 101.29 Mn | -61.98 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 10.00 Mn |
| Dec 31, 2016 | 10.00 Mn |
| Dec 31, 2015 | 10.00 Mn |